The Acne Vulgaris Treatment Market: Trends, Shares, Size, Growth, Opportunity And Forecast 2018-2026

Acne, also known as acne vulgaris, is a common skin condition caused primarily by changes in skin structure. It affects millions of adolescents worldwide. Pimples, blackheads, oily skin, and scarring are common symptoms. There are two types of acne: non-inflammatory and inflammatory, with the latter taking longer to heal and causing permanent damage to the skin. It typically affects skin with a high concentration of sweat glands, such as the upper part of the chest, back, and face. Acne medications are medications that are prescribed to treat acne. Prescription and over-the-counter medications such as retinoids, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, and oral contraceptives are examples.

The rising prevalence of acne diseases is a major factor driving the growth of the acne medication market. Furthermore, other factors driving the Acne Vulgaris Treatment Market include an unhealthy urban lifestyle and the presence of potent acne medications in the pipeline. However, the presence of alternative treatments and the side effects associated with the use of acne medications impede Acne Vulgaris Treatment Market. The development of effective medications with fewer side effects and high market potential in untapped emerging economies, on the other hand, is expected to provide lucrative growth opportunities for the market.

The COVID-19 outbreak, which began in the Chinese city of Wuhan, has now spread globally. The outbreak has affected almost every country. The pandemic has an impact on the Acne Vulgaris Treatment Market because most countries have implemented lockdown measures to combat the pandemic. This pandemic has hampered growth in a wide range of economies. The COVID-19 pandemic has put a strain on healthcare systems around the world, and many dermatology clinics have closed their doors to the public for safety reasons. Several hospitals and clinics have been converted into COVID-19 treatment and isolation centers by utilizing pandemic-designated hospital structures. Furthermore, many patients are unable to visit dermatology clinics or pharmacies to pick up prescriptions due to the lockdown.

 Allergan plc, GlaxoSmithKline plc, Valeant Pharmaceutical International Inc., F.Hoffmann-La Roche AG, Mylan, N.V., Bayer AG, Janssen Pharma Inc., Galderma Inc., Pfizer Inc., and Novan Inc. are key players in the global acne vulgaris treatment market.